IRIS
PETRIOLI, ROBERTO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 4.650
EU - Europa 3.790
AS - Asia 1.747
SA - Sud America 283
AF - Africa 38
OC - Oceania 8
Continente sconosciuto - Info sul continente non disponibili 1
Totale 10.517
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 4.588
RU - Federazione Russa 1.023
GB - Regno Unito 714
CN - Cina 646
SG - Singapore 606
IE - Irlanda 552
IT - Italia 397
SE - Svezia 254
BR - Brasile 234
UA - Ucraina 215
DE - Germania 193
HK - Hong Kong 155
FR - Francia 130
FI - Finlandia 100
VN - Vietnam 95
KR - Corea 77
IN - India 56
CA - Canada 47
ES - Italia 46
BE - Belgio 38
LU - Lussemburgo 22
PL - Polonia 21
BD - Bangladesh 20
AR - Argentina 19
NL - Olanda 17
TR - Turchia 15
CL - Cile 13
MX - Messico 13
CI - Costa d'Avorio 12
JP - Giappone 12
AT - Austria 11
LT - Lituania 11
IQ - Iraq 9
IR - Iran 9
CZ - Repubblica Ceca 8
AE - Emirati Arabi Uniti 7
MA - Marocco 7
ZA - Sudafrica 7
AU - Australia 6
PK - Pakistan 6
RO - Romania 6
VE - Venezuela 5
AZ - Azerbaigian 4
BG - Bulgaria 4
CH - Svizzera 4
DK - Danimarca 4
EC - Ecuador 4
KZ - Kazakistan 4
ID - Indonesia 3
LV - Lettonia 3
NO - Norvegia 3
SA - Arabia Saudita 3
TH - Thailandia 3
UY - Uruguay 3
AL - Albania 2
AO - Angola 2
CO - Colombia 2
DZ - Algeria 2
GR - Grecia 2
HU - Ungheria 2
IL - Israele 2
JO - Giordania 2
KE - Kenya 2
KG - Kirghizistan 2
MW - Malawi 2
NZ - Nuova Zelanda 2
PT - Portogallo 2
PY - Paraguay 2
SI - Slovenia 2
TN - Tunisia 2
TW - Taiwan 2
UZ - Uzbekistan 2
AM - Armenia 1
BA - Bosnia-Erzegovina 1
BO - Bolivia 1
CR - Costa Rica 1
EE - Estonia 1
EG - Egitto 1
ET - Etiopia 1
EU - Europa 1
GE - Georgia 1
KH - Cambogia 1
LA - Repubblica Popolare Democratica del Laos 1
LB - Libano 1
MD - Moldavia 1
MY - Malesia 1
NP - Nepal 1
RS - Serbia 1
SV - El Salvador 1
Totale 10.517
Salva come PNG Salva come JPEG
Città #
Dallas 692
Southend 629
Dublin 547
Fairfield 535
Ashburn 365
Singapore 347
Moscow 311
Woodbridge 250
Chandler 227
Santa Clara 222
Ann Arbor 211
Wilmington 197
Cambridge 188
Seattle 185
Jacksonville 180
Beijing 174
Houston 174
Hong Kong 155
New York 91
Siena 90
Princeton 89
Munich 76
Los Angeles 75
Seoul 75
Hefei 74
Nanjing 56
Shanghai 46
Helsinki 43
San Mateo 39
Brussels 37
Málaga 36
Milan 33
Florence 32
The Dalles 32
Boardman 30
Dong Ket 29
San Diego 26
Columbus 25
Buffalo 23
São Paulo 23
Shenyang 22
London 20
Turku 20
Nanchang 18
Ho Chi Minh City 17
San Francisco 17
Rome 16
Denver 15
Hanoi 15
Jiaxing 15
Council Bluffs 14
Roodt-sur-Syre 14
Warsaw 14
Montreal 13
Redondo Beach 13
Abidjan 12
Atlanta 12
Brooklyn 12
Kunming 12
Nuremberg 12
Toronto 12
Tokyo 11
Hebei 10
Tianjin 10
Venezia 10
Boston 9
Chennai 9
Düsseldorf 9
Guangzhou 9
Pisa 9
Santiago 9
Zhengzhou 9
Arezzo 8
Changsha 8
Chicago 8
Lauterbourg 8
Phoenix 8
Poplar 8
Portsmouth 8
Washington 8
Bengaluru 7
Johannesburg 7
Orem 7
Stockholm 7
Aosta 6
Belo Horizonte 6
Dearborn 6
Dhaka 6
Fremont 6
Jinan 6
Mexico City 6
Norwalk 6
Ottawa 6
Redwood City 6
Zanjan 6
Amsterdam 5
Baghdad 5
Brno 5
Caxias do Sul 5
Elk Grove Village 5
Totale 7.271
Salva come PNG Salva come JPEG
Nome #
C-Met targeting in advanced gastric cancer: An open challenge 303
Efficacy and Safety of Regorafenib With 2/1 Schedule for Patients ≥ 75 Years With Metastatic Colorectal Cancer (mCRC) After Failure of 2 Lines of Chemotherapy 287
Angiogenesis inhibitors in gastric and gastroesophageal junction cancer 280
Pathological response and outcome after neoadjuvant chemotherapy with DOC (docetaxel, oxaliplatin, capecitabine) or EOF (epirubicin, oxaliplatin, 5-fluorouracil) for clinical T3-T4 non-metastatic gastric cancer 274
28. Role of neoadjuvant chemotherapy with cytoreductive surgery combined with hyperthermic intraperitoneal chemotherapy for treatment of primary ovarian cancer with peritoneal carcinomatosis 271
Monoclonal antibodies-based treatment in gastric cancer: current status and future perspectives 255
Feasibility of modified docetaxel, oxaliplatin, capecitabine followed by capecitabine as maintenance chemotherapy as first-line therapy for patients with metastatic gastric or gastroesophageal cancer 254
Analysis of biochemical bone markers as prognostic factors for survival in patients with hormone-resistant prostate cancer and bone metastases 238
Maintenance treatment with oral cyclophosphamide and bevacizumab in patients with recurrent epithelial ovarian cancer 237
Strong Prognostic Value of Microsatellite Instability in Intestinal Type Non-cardia Gastric Cancer 234
Apatinib: A novel receptor tyrosine kinase inhibitor for the treatment of gastric cancer 233
A novel treatment protocol with 6 cycles of neoadjuvant chemotherapy followed by cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (HIPEC) in stage III primary ovarian cancer 231
Signet ring cell percentage in poorly cohesive gastric cancer patients: a potential novel predictor of survival 230
Efficacy of Adjuvant Fluorouracil and Folinic Acid in B2 Colon Cancer 227
Two-point-NGS analysis of cancer genes in cell-free DNA of metastatic cancer patients 227
CEA and CA19.9 as early predictors of progression in advanced/metastatic colorectal cancer patients receiving oxaliplatin-based chemotherapy and bevacizumab 226
Gemcitabine, oxaliplatin, and capecitabine (GEMOXEL) compared with gemcitabine alone in metastatic pancreatic cancer: a randomized phase II study 226
Hyperthermic intraperitoneal chemotherapy for the treatment of ovarian cancer: A brief overview of recent results 225
The percentage of signet ring cells is inversely related to aggressive behavior and poor prognosis in mixed-type gastric cancer 210
Sequential treatment with epirubicin, oxaliplatin and 5FU (EOF) followed by docetaxel, oxaliplatin and 5FU (DOF) in patients with advanced gastric or gastroesophageal cancer: a single-institution experience 198
A case of eribulin-induced regression of liposarcoma of the left funiculus in a heavily pretreated patient 192
Treatment of advanced oesophagogastric cancer with FOLFOX-4 regimen followed by leucovorin/bolus and continuous infusion 5-FU as maintenance chemotherapy in patients aged ≥ 75 years with impaired performance status 185
GEMCITABINE (dFdC), 5-FLUROURACIL (5FU), AND FOLINIC ACID (FA) IN THE TREATMENT OF PATIENTS WITH GASTRO-ENTERIC CARCINOMAS: A CLINICAL AND PHARMACOLOGICAL STUDY. 181
A husband and a wife with simultaneous presentation of glioblastoma multiforme: a case report 178
Gastric cancer: Current status of lymph node dissection 171
Treatment of bone metastases with dichloromethylene bisphosphonate 170
Maximum androgen blockade in advanced prostate cancer: an overview of the randomised trials 170
Capecitabine Plus Oxaliplatin and Bevacizumab, Followed by Maintenance Treatment With Capecitabine and Bevacizumab for Patients Aged > 75 Years With Metastatic Colorectal Cancer 170
Combined tamoxifen and luteinizing hormone-releasing hormone (LHRH) agonist versus LHRH agonist alone in premenopausal advanced breast cancer: A meta-analysis of four randomized trials 166
Short-term and long-term risk factors in gastric cancer 164
The prognostic value of CD3+ tumor-infiltrating lymphocytes for stage II colon cancer according to use of adjuvant chemotherapy: A large single-institution cohort study: TILs for ADJ-untreated stage II colon cancer 164
Hyperprogressive disease in advanced cancer patients treated with nivolumab: a case series study 152
Clinical value and impact on prognosis of peri-operative CA 19-9 serum levels in stage I and II adenocarcinoma of the pancreas 149
Gemcitabine plus nab-paclitaxel followed by maintenance treatment with gemcitabine alone as first-line treatment for older adults with locally advanced or metastatic pancreatic cancer 147
Epirubicin-based compared with docetaxel-based chemotherapy for advanced gastric carcinoma: A systematic review and meta-analysis 144
Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for treatment of ovarian cancer 140
An exceptional overall survival using bevacizumab beyond progression in a patient with Non-small cell lung cancer 139
Cytoreduction surgery (CRS) with hyperthermic intraperitoneal chemotherapy (HIPEC) as treatment choice of metastatic Urachal carcinoma 132
Evolution and emerging future of cytoreducxtive surgery and hyperthermic intraperitoneal chemoperfusion in gastric cancer: From treating the incurable to preventing recurrence 131
Posterior and Para-Aortic (D2plus) Lymphadenectomy after Neoadjuvant/Conversion Therapy for Locally Advanced/Oligometastatic Gastric Cancer 128
Preoperative or perioperative docetaxel, oxaliplatin, and capecitabine (GASTRODOC regimen) in patients with locally-advanced resectable gastric cancer: a randomized phase-II trial 128
Association of Concomitant Bone Resorption Inhibitors with Overall Survival among Patients with Metastatic Castration-Resistant Prostate Cancer and Bone Metastases Receiving Abiraterone Acetate with Prednisone as First-Line Therapy 120
Structured and shared CT radiological report of gastric cancer: a consensus proposal by the Italian Research Group for Gastric Cancer (GIRCG) and the Italian Society of Medical and Interventional Radiology (SIRM) 117
Five years of stable disease with maintenance therapy using bevacizumab and tamoxifen in a patient with metastatic breast cancer 116
null 112
null 112
null 110
null 109
Thymostimulin in Association with Chemotherapy in Breast Cancer Patients with Bone Metastases 107
Specific clonal expansion at disease progression (PD) in solid cancers pinpointed by cell free DNA analysis 106
Squamous cell carcinoma of the maxillary sinus: A retrospective analysis of 36 cases 103
null 103
Impact of HER2 and microsatellite instability status on response to neoadjuvant/conversion therapy and survival in patients with gastric cancer 102
Role of chemotherapy in the treatment of metastatic castration-resistant prostate cancer patients who have progressed after abiraterone acetate 100
Low-Dose Estramustine Phosphate and Concomitant Low-Dose Acetylsalicylic Acid in Heavily Pretreated Patients With Advanced Castration-Resistant Prostate Cancer. 99
null 98
null 98
null 96
null 96
Neuroendocrine tumors' patients treated with somatostatin analogue could complicate with emergency cholecystectomy 94
Tolerability of cabazitaxel in patients with metastatic castration-resistant prostate cancer progressing after docetaxel and abiraterone acetate: a single-institution experience. 93
null 89
null 88
null 87
Surgical management of advanced gastric cancer: An evolving issue 78
Pressurized Intra-Peritoneal Aerosol Chemotherapy (PIPAC) for Peritoneal Malignancies with Palliative and Bidirectional Intent 49
null 39
Totale 10.688
Salva come PNG Salva come JPEG
Categoria #
all - tutte 33.351
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 33.351
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021750 0 0 0 0 0 114 69 178 87 134 85 83
2021/2022717 57 63 50 45 30 38 32 32 34 72 97 167
2022/2023958 56 69 138 107 85 203 31 78 96 46 26 23
2023/2024908 33 16 87 45 27 234 306 9 0 45 48 58
2024/20251.660 63 95 163 116 225 109 33 93 167 54 208 334
2025/20263.052 342 558 582 581 966 23 0 0 0 0 0 0
Totale 10.688